ID LBRM-33 clone 4A2 AC CVCL_6490 SY LBRM-33-4A2; LBRM-33 4A2; 4A2 DR CLO; CLO_0007275 DR ATCC; TIB-155 DR Wikidata; Q54902117 RX Patent=US4404280; RX PubMed=6968790; WW Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=LBRM-33 CC Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981). CC Derived from site: In situ; Spleen; UBERON=UBERON_0002106. CC Cell type: T-cell; CL=CL_0000084. CC Breed/subspecies: B10.BR. DI NCIt; C21602; Mouse lymphoma OX NCBI_TaxID=10090; ! Mus musculus (Mouse) HI CVCL_K174 ! LBRM-33 CA Cancer cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 13 // RX Patent=US4404280; RA Gillis S.; RT "Process for preparing murine interleukin 2 in the presence of RT interleukin 1 from an interleukin 2 nonproducer malignant cell line RT and cell line therefor."; RL Patent number US4404280, 13-Sep-1983. // RX PubMed=6968790; DOI=10.4049/jimmunol.125.6.2570; RA Gillis S., Scheid M.P., Watson J.; RT "Biochemical and biologic characterization of lymphocyte regulatory RT molecules. III. The isolation and phenotypic characterization of RT Interleukin-2 producing T cell lymphomas."; RL J. Immunol. 125:2570-2578(1980). //